Ruellia tuberosa
Ruellia tuberosa · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Ruellia tuberosa is a botanical species that has garnered significant scientific interest due to its diverse range of biological activities. Research focusing on the plant's leaf extracts, specifically in the form of tea (RTEE) and ethanolic preparations, has revealed profound therapeutic potential. These extracts demonstrate notable androgenic, angiogenic, anorexic, and antiadenomic properties within various biological systems. Furthermore, the medicinal value of Ruellia tuberosa is being explored for its ability to address complex conditions such as neuroinflammation and prostate cancer. This makes the plant a compelling subject for further pharmacological investigation into its systemic health benefits.
- Synonyms
- Ruellia Tuberosa Var. Humilis · Ruellia Clandestina · 1 more
- Common names
- Not available
- Family
- Acanthaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Ruellia tuberosa is a versatile plant known by a wide variety of regional and descriptive common names. Many people recognize it by its charming moniker, the Bluebell, which highlights its distinct floral appearance. It is also frequently called the Cracker Plant due to the unique way its seed pods burst when touched. In certain areas, locals may refer to it as Batatilla or even the more dramatic Daniel's great gun. Finally, the plant is often identified as Devil's Bit, showcasing the many identities this single species holds.
Sources: Catalogue of Life (COL)
Synonyms
Ruellia tuberosa is a plant known to be associated with several botanical synonyms in various scientific records. It is frequently identified by the name Dipteracanthus clandestinus in certain taxonomic classifications. Additionally, many researchers and databases recognize the plant under the synonym Ruellia clandestina. The species is also linked to the specific variety known as Ruellia tuberosa var. humilis. Understanding these overlapping names is essential for accurate identification within the botanical community.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Ruellia tuberosa is a fascinating member of the kingdom Plantae. This specific plant belongs to the genus Ruellia and is classified under the family Acanthaceae. Within its biological structure, it is organized under the order Lamiales. Furthermore, it is categorized within the class Equisetopsida. Understanding these taxonomic relationships provides a clear picture of its place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Acanthaceae |
| Genus | Ruellia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ruellia tuberosa exhibits a broad geographical distribution that spans across multiple continents and diverse climates. In Africa, the species is well-established throughout East Tropical Africa, with notable presence in both Kenya and Tanzania. Its reach extends further into the Northeast Tropical region, specifically covering the areas of Sudan and South Sudan. Additionally, the plant can be found in the Western Indian Ocean within the Seychelles archipelago. Beyond Africa, its range extends into the temperate regions of Asia, particularly throughout South-Central China.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ruellia tuberosa is a self-supporting herb that grows with a sturdy and independent structure. This plant typically maintains a compact profile, reaching a maximum height of only 0.5 meters. Because it can range from a ground-level presence to its full stature, its height varies from 0 meters up to its peak. This modest growth form makes it a versatile addition to various garden landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Ruellia tuberosa has demonstrated significant anticancer potential through its application in the biosynthesis of green nanomaterials. By using its leaf extract to produce zinc oxide nanoparticles, researchers have successfully induced apoptosis in human prostate cancer cells. These plant-derived nanoparticles exhibit high cytotoxicity against cancerous cells while maintaining low toxicity toward normal epithelial cells. Molecular analysis reveals that this anticancer activity is specifically mediated through the p53 and STAT3 signaling pathways. Ultimately, this study highlights Ruellia tuberosa as a vital resource for developing cost-effective and eco-friendly alternatives for cancer therapy.
Compounds
Conditions
Ruellia tuberosa demonstrates significant therapeutic potential by exhibiting considerable cytotoxicity toward DU 145 PC cells through the induction of apoptosis. The plant's ethanolic extract serves as a powerful anti-inflammatory agent that effectively treats IL-6 (Interleukin-6) by decreasing its levels in cell line studies. Furthermore, it treats NF-κB (Nuclear factor kappa-B) translocation by suppressing its movement, which confirms its anti-inflammatory characteristics. The extract also treats IL-1β by reducing the levels of this inflammatory cytokine to decrease neuroinflammation. Finally, Ruellia tuberosa treats TNF-α by lowering its presence, contributing to its overall neuroprotective effects.
Preparations
Ruellia tuberosa is prepared as an ethanolic extract, which is also referred to as RTEE in the provided studies. This specific ethanolic extract is utilized to evaluate therapeutic effects on cognitive impairment in rodent models. Additionally, Ruellia tuberosa is prepared as a leaf extract to facilitate the green biosynthesis of zinc oxide nanoparticles. These plant-derived preparations, including the RTEE and the leaf extract, serve as critical components for investigating antioxidant, anti-inflammatory, and anticancer properties. Through these various preparation methods, the medicinal potential of the plant is explored for treating neurodegenerative diseases and prostate cancer.
Parts used
Ruellia tuberosa serves as a vital source of bioactive compounds, specifically through its leaf extract, which can be utilized for green nanotechnology. In recent studies, the leaves of this medicinal plant have been used to facilitate the biosynthesis of zinc oxide nanoparticles. These plant-derived nanoparticles demonstrate significant potential in cancer treatment by inducing apoptosis in human prostate cancer cells. The mechanism of action involves the modulation of key molecular pathways, specifically by boosting p53 expression and suppressing STAT3 signaling. Ultimately, leveraging the leaf extract of Ruellia tuberosa offers a cost-effective and sustainable approach to developing novel anticancer nanomaterials.